title: The synergistic effect of panobinostat (LBH589) with melphalan or doxorubicin on multiple myeloma cells; rationale for the use of combination regimens in myeloma patients.
authors.forename: Evangelos
authors.initials: E
authors.lastname: Terpos
mesh_terms: D000818:Animals; D004317:Doxorubicin / Q000627:therapeutic use*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D056572:Histone Deacetylase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use*; D007211:Indoles; D008558:Melphalan / Q000627:therapeutic use*; D051379:Mice; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology; D000077767:Panobinostat
chemical_list: D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; D007211:Indoles; D004317:Doxorubicin; D000077767:Panobinostat; D008558:Melphalan